Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Yep, that's a great phrase and sums it all up for me.
It's taken time to get this far, but now we've got here the next few years will be phenomenal.
Not many company's manage to marry the science with the market, but there's no doubt that ITX have achieved it, and one of the best parts as far as I'm concerned is that the longer it takes a major to move in on us the more it will cost them. It's a one way street from here.
AJ - I wasn't joking when I said Itaconix would be a division of Unilever. It may not be them specifically but it's only a matter of time before ITX is taken over by one of the majors product manufacturers.
The products being developed by ITX are transformational for the likes of Unilever et all, and they'll take us in-house to stop the competition doing so as much as for their own ends.
It always amazes me how quickly the ITX share price moves.
I understand the mechanics, but it still always surprises me. The fact you can change a Company's market cap by 10% based on transactions worth a total of £20-25k just seems like a very broken system.
Agree re the name, and when it comes down to it every time the Company is mentioned in the press it'll be Evoke (formerly 888) so they may as well not bother.
It really wouldn't surprise me if they revised it up to 275 or even 300 come the formal announcement in April, particularly if the share price has hit 250 prior.
If they do I might (might!) have to give them some credit for a master strategy of putting a higher floor under the share price rather than just screwing over RIs.
Seeking Alpha's Quant System gives PRTC a Strong Buy rating of 4.55 out of 5. In my experience (and I've made investment decisions many times using it's data) Quant is a good indicator of the future success of a stock both near and longer term, although I'm sure to some degree it's a chicken and egg situation as people invest due to the recommendation and hence that makes the recommendation more successful.
For those of you that haven't heard of Quant, Seeking Alpha describe it as an objective evaluation of stocks based on financial data, price performance, analyst estimates, and more. They claim that following it's analysis significantly improves returns against the market average - More info here https://seekingalpha.com/article/4263303-quant-ratings-and-factor-grades-faq
For the record, the 2 Wall Street analysts covering PRTC also give it a Strong Buy rating at 5 out of 5, together with a 12 month price target of over $55, which is just over 100% upside.
I'm happy to hold and wait.
I agree Dallo, but there won't be any shortage of short term traders who are just hoping to make a quick 10-12% on 220p.
It would be quite amusing if they only got to tender 30-40% of their holding.
Good challenge.
I like this board. Informed, knowledgable, balanced and respectful.
Can I persuade a few of you to buy into my other invested Co's and bring some sanity (and intellect) to their boards which are badly in need!? ;-)
Biginersguide - That's exactly what it is. A share by back programme at a small premium to the SP aimed at taking out the RI base. Nothing more.
As Dallo & Malt suggest, change at the top required.
So why so many sells today between 217 and 220, and a share price drop of 2.25%?
Hi Red
I see your angle now, you're basing it on 100% of holders wanting to tender, so therefore they'll only get 14%.
Where as I think they'll be lucky to get 14% tendering so they could have 100% each in my view.
Red - As I said yesterday, I don't think you're limited to applying for 14%, I think you can tender 100% if you like.
The only mention I can see of 14% in the RNS is...
'The capital return of $100 million represents approximately 14% of PureTech's market capitalization based on yesterday's closing price.'
Dallo - I expect the response you will get from Zohar (if you get one at all), is they're giving shorter term shareholders a route out to the ultimate benefit of long term holders.
Yep. Definitely a strategy to get rid of short term retail from the register hoping they'll take a small percentage fast buck and move on.
I think I'll keep every share I've got and see where we end up.
So many green boxes. Soooooo sad.
Just noticed Dallo's comment from 11.09. Pretty much my view on the other thread, but Dallo is more articulate ;-)
£2.75 required to make me even look at the maths again, but PRTC is worth so much more.
The more I think about it, the more I can't think of any reason to sell any at 250.
In fact, it's illogical for anyone not in need of immediate cash to consider it if the SP moves beyond 230 when taking into account all the factors, even if they bought in at 150-160.
I can see a special divi coming and 90% failure on the tender offer.
There's no way PRTC would ever simply delist. It could get taken out by PE or any other major Pharma but it wouldn't delist (which is what I think you mean by being taken private, otherwise if you don't mean that then it's simply a takeover)
I'm never sure about strategy on tender offers, although this one appears better than some I've seen recently so maybe I'd be prepared to let a small percentage of my holding go. What are peoples thoughts?
TIG is making major strides. We need the SP to catch up quickly or the BoD will be fighting off low-ball take over offers.